Bioinspired Hybrid Protein Oxygen Nanocarrier Amplified Photodynamic Therapy for Eliciting Anti-tumor Immunity and Abscopal Effect

ACS Nano
Zhikuan ChenLintao Cai

Abstract

An ideal cancer therapeutic strategy is expected to possess potent ability to not only ablate primary tumors but also prevent distance metastasis and relapse. In this study, human serum albumin was hybridized with hemoglobin by intermolecular disulfide bonds to develop a hybrid protein oxygen nanocarrier with chlorine e6 encapsulated (C@HPOC) for oxygen self-sufficient photodynamic therapy (PDT). C@HPOC realized the tumor-targeted co-delivery of photosensitizer and oxygen, which remarkably relieved tumor hypoxia. C@HPOC was favorable for more efficient PDT and enhanced infiltration of CD8+ T cells in tumors. Moreover, oxygen-boosted PDT of C@HPOC induced immunogenic cell death, with the release of danger-associated molecular patterns to activate dendritic cells, T lymphocytes, and natural killer cells in vivo. Notably, C@HPOC-mediated immunogenic PDT could destroy primary tumors and effectively suppress distant tumors and lung metastasis in a metastatic triple-negative breast cancer model by evoking systemic anti-tumor immunity. This study provides a paradigm of oxygen-augmented immunogenic PDT for metastatic cancer treatment.

References

Jul 12, 2002·Analytical and Bioanalytical Chemistry·Christian K RienerHermann J Gruber
Sep 2, 2004·Nature Medicine·Steven A RosenbergNicholas P Restifo
Jun 24, 2006·Nature Reviews. Cancer·Ana P CastanoMichael R Hamblin
Aug 8, 2006·Nature Medicine·Patricia S Steeg
Apr 18, 2008·Nature Reviews. Cancer·Cornelis J M Melief, Sjoerd H van der Burg
Jan 7, 2011·The New England Journal of Medicine·Joyce O'ShaughnessyCharles Bradley
May 28, 2011·CA: a Cancer Journal for Clinicians·Patrizia AgostinisJakub Golab
Dec 24, 2011·Nature Reviews. Cancer·Avi SchroederDaniel G Anderson
Mar 23, 2012·Nature Reviews. Cancer·Matthew Vanneman, Glenn Dranoff
Nov 16, 2012·Nature Reviews. Cancer·Dmitri V KryskoPeter Vandenabeele
Nov 20, 2012·Annual Review of Immunology·Guido KroemerLaurence Zitvogel
May 21, 2013·Cell Death and Differentiation·A D GargP Agostinis
Dec 24, 2014·Proceedings of the National Academy of Sciences of the United States of America·Yu WangXiaoyuan Chen
Jan 21, 2015·Chemical Reviews·Sasidharan Swarnalatha LuckyYong Zhang
Mar 6, 2015·Science Translational Medicine·Stephen M HatfieldMichail V Sitkovsky
May 13, 2015·Oncoimmunology·Irena AdkinsRadek Špíšek
Sep 19, 2015·Nanoscale·Pengfei RongXiaoyuan Chen
Oct 21, 2015·Advanced Materials·Yi JiaJunbai Li
Apr 26, 2016·Advanced Materials·Qian Chen, Zhuang Liu
Apr 29, 2016·Science·Erinn B Rankin, Amato J Giaccia
Jul 17, 2016·The Journal of Immunology : Official Journal of the American Association of Immunologists·Lanlan LiuYifan Ma
Oct 11, 2016·Chemical Society Reviews·Zijian ZhouXiaoyuan Chen
Oct 11, 2016·Chemical Society Reviews·Wenpei FanXiaoyuan Chen
Nov 1, 2016·Nature Reviews. Immunology·Lorenzo GalluzziGuido Kroemer
Apr 25, 2017·Nature Nanotechnology·Min LuoJinming Gao
Jun 27, 2017·Nature Nanotechnology·Yuanzeng MinAndrew Z Wang
Sep 5, 2017·Nanomedicine·Anna Maria GrimaldiAndrea Soricelli
Sep 29, 2017·Bioconjugate Chemistry·Hamilton KakwereKatherine W Ferrara
Nov 28, 2017·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yongdan ZhaoZhiping Zhang

❮ Previous
Next ❯

Citations

Apr 18, 2019·Angewandte Chemie·Yuyan JiangKanyi Pu
Oct 1, 2019·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Yuhao HaoYuanzeng Min
Nov 12, 2019·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Lu WangWei R Chen
Nov 2, 2019·Pharmaceuticals·Ludivine LarueCéline Frochot
Jan 23, 2020·Nanoscale·Lirong ZhaoXianwei Meng
Jan 31, 2020·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Kaicheng Liang, Hangrong Chen
Jul 30, 2020·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Lina WuXilin Sun
Aug 20, 2020·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Meng WangWei R Chen
Aug 22, 2020·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Xiao-Lin HouBo Liu
Aug 19, 2020·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Lile DongGuobin Hong
Sep 29, 2020·Advanced Healthcare Materials·Huige ZhouChunying Chen
Jan 21, 2019·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Yu ChenJintao Zhu
Feb 9, 2020·Nature Reviews. Clinical Oncology·John D MartinRakesh K Jain
Apr 23, 2020·Cells·Alyssa VitoKaren Mossman
Jun 17, 2020·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Liang ChenYunbing Wang
Jan 29, 2020·Angewandte Chemie·Jiajie ChenStefan Kaskel
Oct 29, 2020·Chemical Society Reviews·Jiajie ChenJianlin Shi
Nov 4, 2020·Cancer Medicine·Lan MingDaozhen Chen
Feb 5, 2021·Archives of Pharmacal Research·Jongyoon ShinnYonghyun Lee
Feb 4, 2021·Bioengineering & Translational Medicine·Debra WuSamir Mitragotri
Feb 11, 2021·International Journal of Molecular Sciences·Hashem O AlsaabYusuf S Althobaiti
Jan 13, 2021·Journal for Immunotherapy of Cancer·Razan AlzeibakDmitri V Krysko
Jan 18, 2021·Cancer Treatment and Research Communications·Ajinkya Madhukar ThanekarAravind Kumar Rengan
Mar 5, 2021·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Qian LiDongming Xing

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.